Latest News about CMMB
Recent news which mentions CMMB
Chemomab Therapeutics Earnings Conference Call Is Coming Up, Here's What You Need To Know
May 04, 2022
Tickers
CMMB
From Benzinga
From Benzinga
Chemomab Therapeutics Reports Q4 EPS $(0.02) Vs. $(0.01) YoY
March 09, 2022
Tickers
CMMB
From Benzinga
Earnings Scheduled For March 9, 2022
March 09, 2022
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 22, 2021
From Benzinga
55 Biggest Movers From Yesterday
December 22, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
December 16, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
December 09, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 7, 2021
December 07, 2021
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 06, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 03, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 02, 2021
From Benzinga
The Daily Biotech Pulse: Moderna, Pfizer-BioNTech Ink New Vaccine Deals With UK, GSK-Vir Antibody Show Activity Against Omicron, Chemomab Gets Clearance
December 02, 2021
From Benzinga
Stock setups for the coming week 15-19 November 2021
November 13, 2021
From AC Investor Blog
54 Biggest Movers From Yesterday
October 22, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
October 21, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
October 21, 2021
From Benzinga
38 Stocks Moving In Thursday's Mid-Day Session
October 21, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 21, 2021
From Benzinga
23 Stocks Moving in Thursday's Pre-Market Session
October 21, 2021
From Benzinga
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
October 12, 2021
From Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
From Benzinga
From Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
From Benzinga
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
October 05, 2021
From Benzinga
Trading setups for next week
October 02, 2021
From AC Investor Blog
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
October 01, 2021
From Benzinga
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
September 30, 2021
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
September 27, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
More ways to get to us
Facebook
Twitter
YouTubeContact the Lethbridge Herald
504 - 7th Street South
Lethbridge, AB T1J 3Z7
[P] (403) 328-4411
[F] (403)328-4536
Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.